Digital Health & Wearables
Dexcom Stelo OTC Continuous Glucose Monitor Reaches One Million Users
Dexcom has announced that its Stelo continuous glucose monitor — the first OTC CGM approved by the FDA — has reached one million users, with the majority being people without diabetes who are using the device for metabolic health optimization.
HealthAI Central Editorial Team·April 18, 2026